This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend Respiratory Professional Care

If you would like more information on the respiratory system, please refer to the NHS website.

Visit the NHS website?

Legal Notice

RESPIRATORY PROFESSIONAL CARE IS SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR RESPIRATORY PROFESSIONAL CARE CAN BE FOUND HERE.

Co-Located Events

Respiratory News

Subpage Hero

     

07 May 2024

Desktop Helper - a practical guide to improve difficult-to-manage asthma in primary care

Desktop Helper - a practical guide to improve difficult-to-manage asthma in primary care

Desktop Helper – A practical guide to improve difficult-to-manage asthma in primary care 

The IPCRG’s desktop helper on difficult-to-manage asthma is available to download. This was freshly published in April 2024. 

Difficult-to-manage asthma is categorised as a person facing these difficulties despite the (apparent) best possible treatment being in place: 

  • Daytime asthma symptoms, more than twice/week 

  • Any night awakening due to asthma-related symptoms 

  • More than two exacerbations per year requiring rescue systemic corticosteroids1 

  • Frequent use of SABA (≥3 canisters per year or ≥3 times per week) 

  • Poor control despite prescription of high-dose ICS often in combination with LABA/LAMA or use of OCS1 

  • Frequent primary care out-of-hours contacts (one or more per month). 

ICS Inhaled corticosteroid, SABA short-acting beta-agonist, LABA long-acting beta-agonist, LAMA long-acting muscarinic antagonist, OCS oral corticosteroid 

Authors include Jaime Correia de Sousa, Dermot Ryan, Garry McDonald, Hanna Sandelowsky, Katarina Stavric, Liam G Heaney, Luís Carvalho, Siân Williams 

Reviewers are Steve Moritz, Vibeke Backer 

The editor is Ian Wright 

Endorsed by European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) 

Funding: The desktop helper was funded from an educational grant from GSK plc. who provided a grant to support the development, typesetting, printing, translation and associated costs but did not contribute to the concept or content of this document.

View all Respiratory News
Loading

Newsletter Sign Up